Sep 28, 2021 09:06 PM (GMT+8) · EqualOcean
AP 28, September, Cape bio bulletin, the company and its wholly owned subsidiary received the notice of grant of invention patent issued by the State Intellectual Property Office recently. The invention provides a primer probe combination for detecting New Coronavirus and its application. The company has used the invention patent technology to develop New Coronavirus 2019-nCoV mutation site / Universal nucleic acid detection kit (PCR- fluorescent probe method), which has been approved by the European Union CE and can be exported to the EU market. However, no domestic medical device registration certificate has yet been obtained.

This text is a result of machine translation.